Promise of antisense oligodeoxynucleotide-based therapy for bladder cancer.

As shown in other cancers, bladder cancer develops as a result of an accumulation of genetic aberrations in normal precursor cells, which occurs through multiple steps, including point mutation, chromosome loss, gene amplification and rearrangement. These alterations cause drastic changes in the phenotype of bladder cancer cells associated with their… CONTINUE READING